MENU
IGMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
IGM Biosciences (IGMS) Ownership - Who owns IGM Biosciences?
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more
Profile
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.74M
P/E Ratio
N/A
Total Cash
152.11M
Projected Growth
N/A
Total Debt
43.96M
Revenue
2.68M
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash/Share
2.53
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
IGMS
Capitalization
72.7M
P/E Ratio
N/A
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash
152M
Total Cash/Share
2.53
Total Debt
44M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
2.68M
ROE
N/A
Book Value
698K
P/B Ratio
104.17
Cash Flow
N/A
Earnings
-3.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
600K
Current Ratio
5.71
Current Revenue Per Employee
9240.74
Dividends Per Share - Security
N/A
EBITDA
-178.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-68.22
Shares Held By Institutions
32.5M
Shares Outstanding - Current
60.1M
Total Liabilities
206M
Total Volume MTD
N/A
Value
-1
Gain YTD
-80.196
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which develops antibodies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com